Author

Lucía Ruiz-Durán

Observed names: Lucía Ruiz‐Durán, Lucía Ruíz Durán, Lucía Ruíz-Durán

Institutions: Universidad de Granada, Instituto de Investigación Biosanitaria de Granada, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

Observed institutions: Universidad de Granada, Instituto de Investigación Biosanitaria de Granada, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

ORCID: 0009-0006-3575-5093

Observed ORCID: 0009-0006-3575-5093

OpenAlex ID: A5118647182

Autophagy and oxidative stress in solid tumors: Mechanisms and therapeutic opportunities

2025 · María Carretero-Fernández, Antonio José Cabrera-Serrano, et al. · Critical Reviews in Oncology/Hematology · 26

Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives

2026 · María Carretero-Fernández, Lucía Ruíz-Durán, et al. · Biomedicine & Pharmacotherapy · 3

Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications

2026 · María Carretero-Fernández, Antonio José Cabrera-Serrano, et al. · Translational Oncology

ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance

2026 · José Manuel Sánchez‐Maldonado, Angelica Macauda, et al. · International Journal of Cancer

A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers

2025 · Antonio José Cabrera-Serrano, Lucía Ruiz-Durán, et al. · Frontiers in Immunology

Works count: 5

Citation count: 29

H-index: 2

I10-index: 1